Procter & Gamble (NYSE:PG – Get Free Report) had its target price lowered by equities researchers at Morgan Stanley from $175.00 to $166.00 in a research note issued to investors on Wednesday,MarketScreener reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price target would suggest a potential upside of 13.88% from the company’s current price.
PG has been the topic of a number of other research reports. UBS Group dropped their target price on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a research report on Tuesday, April 7th. Royal Bank Of Canada dropped their target price on shares of Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating on the stock in a research report on Thursday, April 9th. TD Cowen dropped their target price on shares of Procter & Gamble from $156.00 to $142.00 and set a “hold” rating on the stock in a research report on Wednesday, April 1st. Rothschild & Co Redburn boosted their target price on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a “neutral” rating in a research report on Friday, January 23rd. Finally, Raymond James Financial dropped their target price on shares of Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating on the stock in a research report on Tuesday, April 14th. Twelve investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $162.37.
View Our Latest Report on Procter & Gamble
Procter & Gamble Trading Up 2.0%
Procter & Gamble (NYSE:PG – Get Free Report) last announced its earnings results on Friday, January 23rd. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The business had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. During the same quarter in the previous year, the firm posted $1.88 earnings per share. Procter & Gamble’s revenue was up 1.5% compared to the same quarter last year. As a group, sell-side analysts predict that Procter & Gamble will post 6.96 EPS for the current year.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, insider Susan Street Whaley sold 1,809 shares of the business’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $159.46, for a total value of $288,463.14. Following the sale, the insider owned 30,215 shares of the company’s stock, valued at $4,818,083.90. The trade was a 5.65% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Chairman Jon R. Moeller sold 162,232 shares of the business’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the sale, the chairman directly owned 319,385 shares in the company, valued at $51,884,093.25. This trade represents a 33.68% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 252,715 shares of company stock worth $40,966,904. 0.20% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Procter & Gamble
Several institutional investors and hedge funds have recently bought and sold shares of PG. Brighton Jones LLC boosted its stake in shares of Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after purchasing an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. boosted its stake in shares of Procter & Gamble by 10.6% in the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after purchasing an additional 277 shares in the last quarter. Sivia Capital Partners LLC boosted its stake in shares of Procter & Gamble by 19.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock valued at $979,000 after purchasing an additional 1,016 shares in the last quarter. Auxano Advisors LLC boosted its stake in shares of Procter & Gamble by 10.8% in the 2nd quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock valued at $1,165,000 after purchasing an additional 714 shares in the last quarter. Finally, Schnieders Capital Management LLC. boosted its stake in shares of Procter & Gamble by 2.8% in the 2nd quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock valued at $4,809,000 after purchasing an additional 809 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Key Stories Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: P&G was named #1 in the Household Products category on Fortune’s 2026 “America’s Most Innovative Companies” list — a credibility boost for the company’s product-led growth story and a positive signal for top‑line resilience. Fortune recognition
- Positive Sentiment: Febreze unveiled a new in‑home product (Febreze TRASH) aimed at recurring, high‑frequency use — a tangible example of innovation that can help support market share and recurring sales in home care. Febreze TRASH launch
- Positive Sentiment: Analyst commentary and modelers (TipRanks, others) highlight that PG’s valuation looks more attractive heading into earnings, which can attract buyers if results meet or beat estimates. TipRanks valuation note
- Positive Sentiment: Dividend/total‑return narratives continue to support long‑term demand for PG shares (featured in lists highlighting income stocks), which can underpin steadier flows amid market volatility. Dividend stock feature
- Neutral Sentiment: Multiple previews note analysts expect modest year‑over‑year sales and EPS growth for Q3 (Zacks/consensus revenue ~ $20.6B) — the upcoming print is the main near‑term catalyst; outcome will likely dictate the next directional move. Earnings preview
- Neutral Sentiment: Benzinga and Yahoo previews reiterate that the company’s results will be watched for consumer spending trends — useful context but not new company‑specific news. Benzinga preview
- Neutral Sentiment: P&G management publicly rejected a low‑ball mini‑tender offer — procedural noise that briefly attracts attention but has minimal business impact. Mini‑tender discussion
- Neutral Sentiment: Smaller items (industry features, licensing mentions) surface in niche outlets; they add color but are unlikely to move shares materially near term. Minor licensing note
- Negative Sentiment: Morgan Stanley trimmed its price target to $166 (from $175) while keeping an overweight rating — a lower target can reduce upside expectations even if the firm remains constructive. Morgan Stanley PT cut
- Negative Sentiment: BNP Paribas Exane lowered its target to $165 (from $172) while retaining an outperform call — another downward tweak that trims consensus upside. BNP Paribas PT cut
- Negative Sentiment: Additional firms (BofA, Jefferies) have nudged targets lower in recent weeks; those combined analyst trims have contributed to intraday weakness reported after downgrades. Investors should view these as headwinds that could cap rally if earnings disappoint. BofA / Jefferies notes
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
